Emcure Pharmaceuticals Limited

Sachin Aravind Badhe

Mukund Keshav Gurjar

Samit Satish Mehta

Golakchandra Sudarshan Maikap

Shashikant Gangaram Joshi

Disclosed is process for the preparation of a key Rilpivirine intermediate namely, (E)-4-(2-cyanoethenyl)-2,6-dimethylphenylamine hydrochloride (II) by a process comprising reaction of the tetrafluoroborate salt of the diazonium ion of 2,6-dimethyl-4-amino-1-carboxybenzyl phenylamine (VI) with acrylonitrile in presence of palladium acetate, followed by treatment with an acid and its subsequent conversion to the hydrochloride salt (II), wherein the undesired Z isomer is less than 0.5% and provides Rilpivirine hydrochloride having Z isomer less than 0.1%.

Growing community of inventors

Pune, India

Sachin Aravind Badhe